Endofaster Robot for Gastroesophageal Submucosal Tumors: A Randomized Controlled Study

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorThe First Affiliated Hospital of Soochow University

About this trial

In endoscopic treatment for gastric submucosal tumors arising from the muscularis propria, does robot-assisted surgery yield a higher serosa preservation rate, shorter operative time and lower complication rates than conventional endoscopic procedures?

Eligibility criteria

Qualifiers

Aged 18 to 80 years old;

Submucosal tumors originating from the muscularis propria of gastric fundus, highly suspected as gastrointestinal stromal tumor (GIST) confirmed by endoscopic ultrasonography (EUS) and contrast-enhanced computed tomography (CT);

Tumor diameter ranging from 1.0 cm to 3.0 cm;

No active ulcer or bleeding on the lesion surface before operation;

Disqualifiers

Tumor adhesion to serosa with unclear interface shown on EUS;

High-risk GIST or distant metastasis indicated by imaging or endoscopy;

History of gastric surgery or radiotherapy;

High bleeding risk including coagulation disorders and patients unable to discontinue anticoagulant medications;

Trial design

Treatments tested in this trial

  • Robot system
  • Non-robotic conventional endoscopy

Treatment groups

110 Participants
are divided into 2 treatment groups

Locations

This trial has no locations